Controlled drug release liposome compositions and methods thereof
US10220095B2 · kind B2 · utility
1Cited by
3References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 31, 2017 |
| Grant date | Mar 5, 2019 |
| Priority date | — |
| Expiry date | May 31, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions comprising at least one liposome, at least one polyvalent counterion donor or a pharmaceutically acceptable salt thereof, at least one monovalent counterion donor or a pharmaceutically acceptable salt thereof, and an amphipathic therapeutic agent or a derivative or pharmaceutically acceptable salt thereof. The present invention also relates to methods of inhibiting cancer cell growth while reducing toxicity, comprising administering the pharmaceutical composition described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.